Global Contraceptives Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Contraceptives market size will reach 2,194.78 Million USD in 2025 and is projected to reach 2,635.75 Million USD by 2032, with a CAGR of 2.65% (2025-2032). Notably, the China Contraceptives market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Contraceptives, also known as birth control methods, are various techniques, devices, or medications used to prevent pregnancy by either inhibiting ovulation, fertilization, or implantation of a fertilized egg. There are numerous contraceptive options available, including hormonal methods like birth control pills, patches, and injections, which use synthetic hormones to regulate the menstrual cycle and prevent pregnancy. Barrier methods, such as condoms, diaphragms, and cervical caps, create a physical barrier to block sperm from reaching the egg. Intrauterine devices (IUDs) are small, T-shaped devices inserted into the uterus to prevent pregnancy by altering the uterine environment or sperm movement. Additionally, permanent methods like tubal ligation or vasectomy are surgical procedures that provide long-term contraception. The choice of contraceptive method depends on individual preferences, health considerations, and the level of effectiveness desired, making contraception a critical aspect of family planning and reproductive health.
The major global suppliers of Contraceptives include Bayer AG, Pfizer, Teva Pharmaceutical Industries Ltd, Merck & Co, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine, Reckitt, AbbVie, Church & Dwight, TherapeuticsMD, The Cooper Companies, Afaxys, Mithra Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Contraceptives. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Contraceptives market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Contraceptives market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Contraceptives industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Contraceptives Include:
Bayer AG
Pfizer
Teva Pharmaceutical Industries Ltd
Merck & Co
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
TherapeuticsMD
The Cooper Companies
Afaxys
Mithra Pharmaceuticals
Contraceptives Product Segment Include:
Pill
Injection
Condom
Vaginal Ring
IUDs
Subcutaneous Implant
Other
Contraceptives Product Application Include:
15–24 years
25–34 years
35–44 years
Above 44 years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Contraceptives Industry PESTEL Analysis
Chapter 3: Global Contraceptives Industry Porter's Five Forces Analysis
Chapter 4: Global Contraceptives Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Contraceptives Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Contraceptives Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Contraceptives Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Contraceptives market size will reach 2,194.78 Million USD in 2025 and is projected to reach 2,635.75 Million USD by 2032, with a CAGR of 2.65% (2025-2032). Notably, the China Contraceptives market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Contraceptives, also known as birth control methods, are various techniques, devices, or medications used to prevent pregnancy by either inhibiting ovulation, fertilization, or implantation of a fertilized egg. There are numerous contraceptive options available, including hormonal methods like birth control pills, patches, and injections, which use synthetic hormones to regulate the menstrual cycle and prevent pregnancy. Barrier methods, such as condoms, diaphragms, and cervical caps, create a physical barrier to block sperm from reaching the egg. Intrauterine devices (IUDs) are small, T-shaped devices inserted into the uterus to prevent pregnancy by altering the uterine environment or sperm movement. Additionally, permanent methods like tubal ligation or vasectomy are surgical procedures that provide long-term contraception. The choice of contraceptive method depends on individual preferences, health considerations, and the level of effectiveness desired, making contraception a critical aspect of family planning and reproductive health.
The major global suppliers of Contraceptives include Bayer AG, Pfizer, Teva Pharmaceutical Industries Ltd, Merck & Co, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine, Reckitt, AbbVie, Church & Dwight, TherapeuticsMD, The Cooper Companies, Afaxys, Mithra Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Contraceptives. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Contraceptives market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Contraceptives market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Contraceptives industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Contraceptives Include:
Bayer AG
Pfizer
Teva Pharmaceutical Industries Ltd
Merck & Co
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
TherapeuticsMD
The Cooper Companies
Afaxys
Mithra Pharmaceuticals
Contraceptives Product Segment Include:
Pill
Injection
Condom
Vaginal Ring
IUDs
Subcutaneous Implant
Other
Contraceptives Product Application Include:
15–24 years
25–34 years
35–44 years
Above 44 years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Contraceptives Industry PESTEL Analysis
Chapter 3: Global Contraceptives Industry Porter's Five Forces Analysis
Chapter 4: Global Contraceptives Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Contraceptives Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Contraceptives Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Contraceptives Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Contraceptives Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Contraceptives Product by Type
- 1.2.1 Pill
- 1.2.2 Injection
- 1.2.3 Condom
- 1.2.4 Vaginal Ring
- 1.2.5 IUDs
- 1.2.6 Subcutaneous Implant
- 1.2.7 Other
- 1.3 Contraceptives Product by Application
- 1.3.1 15–24 years
- 1.3.2 25–34 years
- 1.3.3 35–44 years
- 1.3.4 Above 44 years
- 1.4 Global Contraceptives Market Size Analysis (2020-2032)
- 1.5 Contraceptives Market Development Status and Trends
- 1.5.1 Contraceptives Industry Development Status Analysis
- 1.5.2 Contraceptives Industry Development Trends Analysis
- 2 Contraceptives Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Contraceptives Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Contraceptives Market Analysis by Country
- 4.1 Global Contraceptives Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Contraceptives Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Contraceptives Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.5 China Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.6 France Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.14 India Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Contraceptives Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Contraceptives Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Contraceptives Market Revenue by Key Suppliers (2021-2025)
- 5.2 Contraceptives Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Contraceptives Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Contraceptives Market Analysis by Type
- 6.1 Global Contraceptives Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Contraceptives Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Bayer AG
- 7.1.1 Bayer AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Bayer AG Contraceptives Product Portfolio
- 7.1.3 Bayer AG Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Pfizer
- 7.2.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Pfizer Contraceptives Product Portfolio
- 7.2.3 Pfizer Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Teva Pharmaceutical Industries Ltd
- 7.3.1 Teva Pharmaceutical Industries Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
- 7.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Merck & Co
- 7.4.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Merck & Co Contraceptives Product Portfolio
- 7.4.3 Merck & Co Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Actavis
- 7.5.1 Actavis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Actavis Contraceptives Product Portfolio
- 7.5.3 Actavis Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Johnson & Johnson
- 7.6.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Johnson & Johnson Contraceptives Product Portfolio
- 7.6.3 Johnson & Johnson Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Gedeon Richter
- 7.7.1 Gedeon Richter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Gedeon Richter Contraceptives Product Portfolio
- 7.7.3 Gedeon Richter Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Novo Nordisk A/S
- 7.8.1 Novo Nordisk A/S Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Novo Nordisk A/S Contraceptives Product Portfolio
- 7.8.3 Novo Nordisk A/S Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 ZiZhu
- 7.9.1 ZiZhu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 ZiZhu Contraceptives Product Portfolio
- 7.9.3 ZiZhu Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Baijingyu
- 7.10.1 Baijingyu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Baijingyu Contraceptives Product Portfolio
- 7.10.3 Baijingyu Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Huazhong
- 7.11.1 Huazhong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Huazhong Contraceptives Product Portfolio
- 7.11.3 Huazhong Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Sine
- 7.12.1 Sine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Sine Contraceptives Product Portfolio
- 7.12.3 Sine Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Reckitt
- 7.13.1 Reckitt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Reckitt Contraceptives Product Portfolio
- 7.13.3 Reckitt Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 AbbVie
- 7.14.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 AbbVie Contraceptives Product Portfolio
- 7.14.3 AbbVie Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Church & Dwight
- 7.15.1 Church & Dwight Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Church & Dwight Contraceptives Product Portfolio
- 7.15.3 Church & Dwight Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 TherapeuticsMD
- 7.16.1 TherapeuticsMD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 TherapeuticsMD Contraceptives Product Portfolio
- 7.16.3 TherapeuticsMD Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 The Cooper Companies
- 7.17.1 The Cooper Companies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 The Cooper Companies Contraceptives Product Portfolio
- 7.17.3 The Cooper Companies Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.18 Afaxys
- 7.18.1 Afaxys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 Afaxys Contraceptives Product Portfolio
- 7.18.3 Afaxys Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.19 Mithra Pharmaceuticals
- 7.19.1 Mithra Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Mithra Pharmaceuticals Contraceptives Product Portfolio
- 7.19.3 Mithra Pharmaceuticals Contraceptives Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Contraceptives Industry Chain Analysis
- 8.2 Contraceptives Product Downstream Application Analysis
- 8.2.1 Global Contraceptives Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Contraceptives Revenue and Forecast by Application (2020-2032)
- 8.3 Contraceptives Typical Downstream Customers
- 8.4 Contraceptives Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
